Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of atomoxetine treatment in humans.

Trial Profile

Effects of atomoxetine treatment in humans.

Phase of Trial: Phase I/II

Latest Information Update: 07 Aug 2018

At a glance

  • Drugs Atomoxetine (Primary)
  • Indications Attention-deficit hyperactivity disorder; Parkinson's disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Sep 2010 Actual end date (September 2009) added as reported by ClinicalTrials.gov.
    • 24 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top